Identifying Predominant Causes of Death Among Hospitalized COVID-19 Patients During Poland's Second and Third Waves

Irina Niecwietajewa1, Michał Frączek2, Maria Mroczkowska3

  • 1Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland.

Insights

This study found a 35% mortality rate among 581 hospitalized COVID-19 patients in Poland from November 2020 to May 2021. Leading causes of death included lung damage and bacterial superinfections, highlighting severe COVID-19 morbidity and mortality.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Critical Care Medicine

Background:

  • Poland experienced high COVID-19 mortality rates in Europe between November 2020 and May 2021.
  • This study investigated morbidity and mortality in hospitalized COVID-19 patients during this period.

Purpose of the Study:

  • To evaluate morbidity and mortality rates in patients hospitalized with severe COVID-19.
  • To identify primary causes of death in hospitalized COVID-19 patients.

Main Methods:

  • A retrospective, single-center study analyzed data from 581 hospitalized COVID-19 patients.
  • Charlson Comorbidity Index assessed multimorbidity; COVID-19 diagnosis confirmed by RT-PCR.
  • Statistical analysis performed using IBM SPSS Statistics.

Main Results:

  • The overall mortality rate was 35% among admitted patients.
  • Leading causes of death were lung damage (60%), bacterial superinfection (26%), and thromboembolism (9%).
  • A significant relationship was found between sex and cause of death (COVID-19 pneumonia, VAP).

Conclusions:

  • Severe COVID-19 patients faced high morbidity and mortality before widespread vaccination and effective treatments.
  • Findings underscore the critical impact of COVID-19 during the study period.
  • Bacterial superinfections and lung damage were significant contributors to mortality.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
248
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
242
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
296